New indications for the intravenous use of papaverine and perparin.
D002317:Cardiovascular Agents; D007275:Injections, Intravenous; D009125:Muscle Relaxants, Central / Q000628:therapy*; D010208:Papaverine / Q000628:therapy*
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010208:Papaverine
MUSCLE RELAXANTS/therapy; PAPAVERINE/therapy